Ondansetron 83980-0013
Product NDC
83980-0013- Manufacturer
- Ipca Laboratories Limited
- Dosage Form
- Tablet, Orally Disintegrating
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 19, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA209389
Need to source Ondansetron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ondansetron | 8 mg/1 |
Drug Class
Serotonin-3 Receptor Antagonist [EPC]Serotonin 3 Receptor Antagonists [MoA]Serotonin-3 Receptor Antagonist [EPC]
Packaging Options(4)
100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-01)
1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-10)
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-13)
3 BLISTER PACK in 1 CARTON (83980-013-83) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK